{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T03:51:17Z","timestamp":1775361077976,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Isr J Health Policy Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite Israel\u2019s increased use of prescription opioids, reported deaths resulting or associated with opioids have decreased, in fact dramatically, since 2005. This contrast is unique and difficult to explain. We sought to examine whether higher prescribed opioid dosages among adults without oncologic diagnoses were associated with higher all-cause mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A historical cohort study in Clalit Health Services, using a data repository including all adult patients prescribed opiates between 2010 and 2020, excluding patients with oncologic diagnoses. Patients were classified into three groups according to opioid use: below 50 Morphine milligram equivalents (MME) per day, 50 to 90 MME per day, and above 90 MME per day. Sex, Charlson comorbidity score, age and socioeconomic status were recorded. Mortality rates were compared between the dosage groups and compared to age-standardized mortality rates in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On multivariate analysis, patients receiving 90 or more MME per day were 2.37 (95%CI 2.1 to 2.68) more likely to have died compared to patients receiving below 50 MME per day. The respective hazard ratio among patients receiving between 50 and 90 MME per day was 2.23 (2.01 to 2.46). Among patients aged 18 to 50, standardized mortality ratios (SMRs)\u00a0compared to the general population ranged between 5.4 to 8.6 among women, receiving between 50 and 90 MME per day, and between 8.07 and 10.7 among women receiving 90 or more MME per day. The respective SMRs among men were 1.2 to 3.8 and 2.7 to 5.4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased opioid use is independently associated with increased all-cause mortality among non-oncological patients. This result is most notable among young adults with little or no known comorbidities. These findings are consistent with results in other countries and seem more credible than previous Israeli reports. Healthcare regulators and providers should, therefore, act to curtail the increasing opioid prescriptions and devise and enhance controls in the healthcare system, which, until 2020, had very limited mechanisms in place.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13584-024-00606-y","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:02:45Z","timestamp":1712120565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Receipt of prescription opioid medication is associated with increased mortality in an Israeli population"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-2216","authenticated-orcid":false,"given":"Matan J.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuven L.","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Kaliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"606_CR1","volume-title":"Are we nearing an opioid epidemic in Israel?","author":"N Davidovitch","year":"2023","unstructured":"Davidovitch N, Kranzler Y, Miron O. Are we nearing an opioid epidemic in Israel? Taub Center for Social Policy Studies in Israel; 2023."},{"issue":"1","key":"606_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13584-023-00558-9","volume":"12","author":"B Shapira","year":"2023","unstructured":"Shapira B, Berkovitz R, Haklai Z, Goldberger N, Lipshitz I, Rosca P. Trends and correlated outcomes in population-level prescription opioid and transdermal fentanyl use in Israel. Isr J Health Policy Res. 2023;12(1):9.","journal-title":"Isr J Health Policy Res."},{"issue":"5","key":"606_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/pds.4415","volume":"27","author":"AM Ponizovsky","year":"2018","unstructured":"Ponizovsky AM, Marom E, Weizman A, Schwartzberg E. Changes in consumption of opioid analgesics in Israel 2009 to 2016: an update focusing on oxycodone and fentanyl formulations. Pharmacoepidemiol Drug Saf. 2018;27(5):535\u201340.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"606_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13584-023-00581-w","volume":"12","author":"RL Dressler","year":"2023","unstructured":"Dressler RL, Kaliner E, Cohen MJ. Trends in Israeli community-based opioid prescribing, 2010-2020, an observational study of the country's largest HMO. Isr J Health Policy Res. 2023;12(1):34.","journal-title":"Isr J Health Policy Res."},{"issue":"2","key":"606_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","volume":"6","author":"HJ Curtis","year":"2019","unstructured":"Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B. Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study. Lancet Psychiatry. 2019;6(2):140\u201350.","journal-title":"Lancet Psychiatry."},{"issue":"1","key":"606_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/dar.12089","volume":"33","author":"B Fischer","year":"2014","unstructured":"Fischer B, Jones W, Urbanoski K, Skinner R, Rehm J. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev. 2014;33(1):19\u201326.","journal-title":"Drug Alcohol Rev."},{"issue":"26","key":"606_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697\u2013704.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"606_CR8","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2219","volume":"64","author":"M Pierce","year":"2021","unstructured":"Pierce M, van Amsterdam J, Kalkman GA, Schellekens A, van den Brink W. Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur Psychiatry. 2021;64(1):e47.","journal-title":"Eur Psychiatry."},{"issue":"5","key":"606_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/rapm-2020-101924","volume":"46","author":"O Miron","year":"2020","unstructured":"Miron O, Zeltzer D, Shir T, Balicer RD, Einav L, Feldman BS. Rising opioid prescription fulfillment among non-cancer and non-elderly patients-Israel's alarming example. Reg Anesth Pain Med. 2020;46(5):455\u20136.","journal-title":"Reg Anesth Pain Med."},{"issue":"2","key":"606_CR10","doi-asserted-by":"publisher","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","volume":"1","author":"T Gomes","year":"2019","unstructured":"Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2019;1(2):e180217.","journal-title":"JAMA Netw Open."},{"issue":"29","key":"606_CR11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","volume":"71","author":"M Kariisa","year":"2022","unstructured":"Kariisa M, Davis NL, Kumar S, Seth P, Mattson CL, Chowdhury F, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics - 25 states and the District of Columbia, 2019-2020. MMWR Morb Mortal Wkly Rep. 2022;71(29):940\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"50","key":"606_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.15585\/mmwr.mm7150a2","volume":"71","author":"LJ Tanz","year":"2022","unstructured":"Tanz LJ, Dinwiddie AT, Mattson CL, O'Donnell J, Davis NL. Drug overdose deaths among persons aged 10-19 years - United States, July 2019-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(50):1576\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"6","key":"606_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000485033","volume":"23","author":"D Feingold","year":"2017","unstructured":"Feingold D, Goldberger N, Haklai Z, Lev-Ran S. Fatal overdoses of opioids in Israel 2005-2014. Eur Addict Res. 2017;23(6):276\u201383.","journal-title":"Eur Addict Res."},{"key":"606_CR14","volume-title":"Summary of the activities of the Department for the Treatment of addictions - mental health division","author":"P Roshka","year":"2019","unstructured":"Roshka P, Spivak P, Goldman K, Austin A. Summary of the activities of the Department for the Treatment of addictions - mental health division. Israel: Health Ministry; 2019."},{"issue":"5","key":"606_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis."},{"key":"606_CR16","first-page":"100612","volume":"27","author":"M Hernandez-Avila","year":"2023","unstructured":"Hernandez-Avila M, Ortiz-Brizuela E, Tamayo-Ortiz M, Zepeda-Tello R, Gutierrez-Diaz H, Barros-Sierra Cordera D, et al. Assessing the real-world effectiveness of five SARS-CoV-2 vaccines in a cohort of Mexican pensioners: a nationwide nested test-negative design study. Lancet Reg Health Am. 2023;27:100612.","journal-title":"Lancet Reg Health Am."},{"issue":"11","key":"606_CR17","doi-asserted-by":"publisher","first-page":"e2342398","DOI":"10.1001\/jamanetworkopen.2023.42398","volume":"6","author":"TL Onyewuenyi","year":"2023","unstructured":"Onyewuenyi TL, Peterman K, Zaritsky E, Ritterman Weintraub ML, Pettway BL, Quesenberry CP, et al. Neighborhood disadvantage, race and ethnicity, and postpartum depression. JAMA Netw Open. 2023;6(11):e2342398.","journal-title":"JAMA Netw Open."},{"issue":"12","key":"606_CR18","doi-asserted-by":"publisher","first-page":"e076803","DOI":"10.1136\/bmjopen-2023-076803","volume":"13","author":"C Swarbrick","year":"2023","unstructured":"Swarbrick C, Poulton T, Martin P, Partridge J, Moppett IK, Team SP. Study protocol for a national observational cohort investigating frailty, delirium and multimorbidity in older surgical patients: the third Sprint National Anaesthesia Project (SNAP 3). BMJ Open. 2023;13(12):e076803.","journal-title":"BMJ Open."},{"key":"606_CR19","unstructured":"Israeli, Social, Security. Membership in Health Maintenance Organizations - Synopsis - Israeli Social Security 2023 [Available from: https:\/\/www.btl.gov.il\/Mediniyut\/Situation\/haveruth1\/Pages\/default.aspx."},{"issue":"6","key":"606_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","volume":"24","author":"M Von Korff","year":"2008","unstructured":"Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521\u20137.","journal-title":"Clin J Pain."},{"issue":"15","key":"606_CR21","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA."},{"key":"606_CR22","unstructured":"Israeli, Central, Bureau, of, Statistics. [Available from: https:\/\/www.cbs.gov.il\/en\/publications\/Pages\/2022\/Complete-Life-Tables-of-Israel-2016-2020.aspx."},{"key":"606_CR23","unstructured":"Greenberg N. Addiction to Fentanyl Patches in Israel - background data for parliamentary committee: Israeli Parliment - The Knesset; 2023 [Available from: https:\/\/main.knesset.gov.il\/activity\/info\/research\/pages\/incident.aspx?rid=7579&businesstype=1."},{"key":"606_CR24","first-page":"100437","volume":"19","author":"B Fischer","year":"2023","unstructured":"Fischer B. The continuous opioid death crisis in Canada: changing characteristics and implications for path options forward. Lancet Reg Health Am. 2023;19:100437.","journal-title":"Lancet Reg Health Am."},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"e9461","DOI":"10.7717\/peerj.9461","volume":"8","author":"B Shapira","year":"2020","unstructured":"Shapira B, Rosca P, Berkovitz R, Gorjaltsan I, Neumark Y. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ. 2020;8:e9461.","journal-title":"PeerJ."},{"key":"606_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/DDDT.S342409","volume":"16","author":"A Kotlinska-Lemieszek","year":"2022","unstructured":"Kotlinska-Lemieszek A, Zylicz Z. Less well-known consequences of the long-term use of opioid analgesics: a comprehensive literature review. Drug Des Devel Ther. 2022;16:251\u201364.","journal-title":"Drug Des Devel Ther."},{"issue":"11","key":"606_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Ht S, Davis NL. Drug and opioid-involved overdose deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep."}],"container-title":["Israel Journal of Health Policy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-024-00606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13584-024-00606-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-024-00606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:06:12Z","timestamp":1712120772000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijhpr.biomedcentral.com\/articles\/10.1186\/s13584-024-00606-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/s13584-024-00606-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3360990\/v1","asserted-by":"object"}]},"ISSN":["2045-4015"],"issn-type":[{"value":"2045-4015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u25e6 CHS ethics committee approval COM1\u2013159-19.\u25e6 All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.\u25e6 The dataset used for this study was anonymized and there was no requirement for participant consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NR.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}